Literature DB >> 27592262

Aggressive anti-inflammatory treatment for refractory Kawasaki disease.

Stephen Owens1, Philipp Agyeman1, Martin Whyte1, David Crossland2, Terence Flood1, Mario Abinun3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27592262     DOI： 10.1016/j.jinf.2016.08.015

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  2 in total

1.  Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease.

Authors:  Wei Zhang; Yan Wang; Yiwen Zeng; Liyi Hu; Guotao Zou
Journal:  Biomed Res Int       Date:  2017-06-01       Impact factor: 3.411

Review 2.  Kawasaki syndrome: role of superantigens revisited.

Authors:  Donald Y M Leung; Patrick M Schlievert
Journal:  FEBS J       Date:  2020-08-24       Impact factor: 5.622
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.